Company intelligence / Profile preview

Novocol Pharma

Cambridge, Ontario, Canada

Ownership: Private
Development stage: Commercial

Overview

Novocol Pharma is an established Canadian contract development and manufacturing organization specializing in aseptic fill-finish for sterile injectables, including small molecules, peptides, and vaccines. The company has recently expanded its state-of-the-art facility to support both clinical and commercial production. It is recognized for strategic partnerships with global biopharma companies—including Moderna—for domestic vaccine supply chain security. No proprietary clinical results as it does not develop its own drugs

Modalities: Small moleculePeptidesVaccine
Industry: Contract Manufacturing Organization

Drug pipeline

1 asset

mepivacaine + adrenaline

Commercial

Indications: Anesthesia

Partnerships

Moderna (fill-finish agreement for mRNA vaccines)

Beyond the preview

Go deeper on Novocol Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novocol Pharma.

Explore the full profile